Arsenic helps prolong life for leukemia patients

According to a new study presented in Chicago (USA), arsenic, a well-known toxin, has the potential to prolong the lives of patients with chronic leukemia, a rare form of blood cancer if possible. combined with standard therapy.

A child with leukemia (Photo: HTV)

Professor Bayard Powell of Wake Forest (North Carolina) Center of Hematology, the lead author of the study, presented the experimental results at the 43rd conference of the Blood Cancer Association. More than 25,000 experts attended the conference held over the weekend.

Phase 3 clinical trials were conducted in 518 adults of chronic leukemia.

The researchers noted that in 261 patients treated with arsenic therapy with conventional drugs, the survival rate was 86% after 3 years compared with 77% for therapy-treated patients. Standard France.

Power